PATENT CLAIM ANALYSIS

Application Number: 15774795
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "04400A"]

Abstract:
Provided are RNA inhibitory molecules, particularly siRNA molecules silencing the expression of Voltage-Dependent Ion Chanel-1 (VDAC1) for the induction of cancer stem cell differentiation and reduction of TAMs abundance and tumor angiogenesis, thereby preventing tumor invention and recurrence.

Claim (Index 47):
The method of  claim 39 , wherein the VDAC1-silencing oligonucleotide is selected from the group consisting of RNA interference (RNAi) molecule and antisense molecule.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 93.0
- Lexical Diversity: 1.22857
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12088896', '12015325', '15554360', '12296239', '14239120']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8034763456466233
- 35 USC 102 Novelty (BERT): 0.5465635146725005
- Combined Prediction Score: 0.777785062549211
- Mean Citation Score: 327.479394
- Max Citation Score: 398.54028
- Similarity Product: 275.350183995409

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test